Recent Blog Articles
Can wearing contacts harm your vision?
Vegan and paleo: Pluses and minuses to watch
Postpartum anxiety is invisible, but common and treatable
Right-sizing opioid prescriptions after surgery
Ready for your routine medical checkup?
Nicotine addiction explained — and how medications can help
Is your vision impaired? Tips to cope
Misgendering: What it is and why it matters
Healthy brain, healthier heart?
Stories connect us
Harvard Health Blog
New drugs approved for advanced BRCA-positive prostate cancer
- By: Charlie Schmidt, Editor, Harvard Medical School Annual Report on Prostate Diseases
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles. No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.
My husband has just completed his 7 out of 10 chemotherapy. His cocktail is given intravenously every 3 weeks with one change after treatment 5, one radiation treatment. On July 9 he is scheduled for ct and bone scan. These are to decide next course of action. I know every man’s prostrate cancer is different. Unfortunately that deciding factor hit him hard with his FIRST Doctors appointment, psa levels of 50, already metastatic cancer in his lymph-nodes.
I’m excited to share with these studies with his Oncologist! We live in Canada 🇨🇦. What is the cost of the Annual Report on Prostrate Cancer edition?
With all this uncertainty in our world, I continue to thank those in the Medical Profession for their nonstop determination in all health areas!
Commenting has been closed for this post.
American Heart Association issues statement on cardiovascular side effects from hormonal therapy for prostate cancer
An emerging treatment option for men with recurring prostate cancer after radiation therapy